标题: CASI Pharma上涨15％ [打印本页] 作者: StephenW 时间: 2018-12-1 12:58 标题: CASI Pharma上涨15％
CASI Pharma up 15%
Nov. 30, 2018 11:26 AM ET|About: CASI Pharmaceuticals (CASI)|By: Douglas W. House, SA News Editor
Thinly traded micro cap CASI Pharmaceuticals (CASI +15.1%) clears brief consolidation on average volume. Shares have rallied 60% in a month.
In late October, it acquired Laurus Labs' U.S. marketing authorization (ANDA) for its generic version of tenofovir disoproxil fumarate (TDF) for the treatment of hepatitis B virus (HBV) infection for $700K upfront and up to $2.3M in milestones. It plans to commercialize the product in China.
Yesterday after the close, the SEC declared its prospectus for the resale of up to ~9.1M common shares from existing investors effective.
CASI Pharma上涨15％
2018年11月30日东部时间上午11:26 |关于：CASI Pharmaceuticals（CASI）|作者：Douglas W. House，SA新闻编辑